Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Invivoscribe logo — Improving Lives with Precision Diagnostics®

Invivoscribe

Improving Lives with Precision Diagnostics®

Founded 1995 United States San Diego, United States 199 employees Biotechnology, Health Care

General Information

Company Name Invivoscribe
Founded Year 1995
Location United States San Diego, United States +5
Employees 199
Industries Biotechnology, Health Care
Social

Get notified when Invivoscribe moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Invivoscribe

Invivoscribe® is a global leader in the biotechnology and healthcare industries, founded in 1995 with its headquarters in the United States. The company is dedicated to Improving Lives with Precision Diagnostics® and focuses on advancing the quality of healthcare through its innovative products and clinical services for oncology. Invivoscribe® operates with a streamlined CDx® (companion diagnostic) model, which accelerates the development of novel therapeutics, enabling personalized approaches to patient care. The company offers a comprehensive range of platform-agnostic assays, reagents, controls, and software for clonal gene rearrangements, translocations, gene mutation testing, and measurable residual disease (MRD). Through its subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM®), Invivoscribe® provides extensive clinical diagnostic and biopharma services for the detection and monitoring of myelo- and lymphoproliferative disorders. The LabPMM network performs globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations, catering to patient care in the U.S., Europe, and Asia. Invivoscribe® consistently surpasses industry and regulatory standards, playing a crucial role in identifying, stratifying, and monitoring hematologic cancers, thereby enabling scientific advancements and empowering clinicians to make informed treatment decisions. The company is dedicated to revolutionizing oncology diagnostics and improving patient outcomes worldwide. In summary, Invivoscribe® has established itself as a key player in precision medicine, offering a wide range of innovative products and services that are vital for the advancement of oncology diagnostics and patient care.

Taxonomy: precision diagnostics, oncology, companion diagnostics, therapeutics, cGMP facility, clonal gene rearrangements, gene mutation testing, measurable residual disease, molecular testing, precision medicine, biopharma services, clinical diagnostics, flow cytometry, global healthcare

No funding data available for Invivoscribe yet.

Get notified when Invivoscribe raises funding

Invivoscribe Alternatives & Competitors

Invivoscribe vs
Biocartis
Biocartis Belgium

High precision diagnostics for personalized medicine

Grant
314 employees
Biotechnology, Health Care
Invivoscribe vs
Tongshu Gene
Tongshu Gene

Advancing oncology care with molecular insights and personalized strategies.

Series C
Life Sciences, Medical Devices
Invivoscribe vs
Qualisure Diagnostics Inc.
Qualisure Diagnostics Inc. Canada

Deploying AI-enabled molecular diagnostics globally through decentralized testing and centralized in...

Seed
10 employees
Biotechnology, Health Care

FAQ About Invivoscribe

Improving Lives with Precision Diagnostics®
Invivoscribe was founded in 1995.
Invivoscribe is headquartered in San Diego, United States.
Invivoscribe operates in the following industries: Biotechnology, Health Care.
Invivoscribe has approximately 199 employees.
Top alternatives and competitors to Invivoscribe include Biocartis, Tongshu Gene, Qualisure Diagnostics Inc., Empire Genomics, Xcoo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Invivoscribe and Biocartis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Invivoscribe and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes